Assad J. Kazeminy - Feb 13, 2023 Form 4 Insider Report for Lucy Scientific Discovery, Inc. (LSDI)

Role
Chief Scientific Officer
Signature
/s/ Christopher McElvany, Attorney-in-Fact
Stock symbol
LSDI
Transactions as of
Feb 13, 2023
Transactions value $
$204,000
Form type
4
Date filed
2/15/2023, 07:56 PM
Previous filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSDI Common Shares Other $204K +85K $2.40 85K Feb 13, 2023 ALK Biopharmaceutical LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These common shares were issued AJK Biopharmaceutical LLC ("AJK") pursuant to a debt settlement with the Issuer in satisfaction of approximately $204,000 due to AJK in consulting fees.
F2 The securities are held by AJK Biopharmaceutical LLC ("AJK"). The reporting person is the sole member of AJK. The reporting persons disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.